Medications

Relugolix superior to leuprolide in advanced prostate cancer

(HealthDay)—For men with advanced prostate cancer, the oral gonadotropin-releasing hormone (GnRH) antagonist relugolix maintains testosterone suppression compared with the GnRH agonist leuprolide, while enzalutamide is ...

Medical research

New discovery explains how the prostate gland regenerates itself

The standard treatment for men with advanced prostate cancer is androgen-deprivation therapy. Androgens are hormones that fuel prostate cell growth; removing them with either drugs or surgery causes the prostate gland to ...

Oncology & Cancer

Being overweight may raise your risk for advanced prostate cancer

A new study links being overweight in middle age and later adulthood to a greater risk of advanced prostate cancer. Jeanine Genkinger, Ph.D., an epidemiologist at Columbia University Mailman School of Public Health, and colleagues ...

page 8 from 11